APOTEX CORP.

• APOTEX CORP. $3,140,000 6 filings

• S 43
  Skinny Labels, Big Savings Act
  4 filings
• HR 1483
  Protecting Investors’ Personally Identifiable Information Act
  2 filings
• HR 6485
  Skinny Labels, Big Savings Act
  2 filings
• S 1302
  Increasing Transparency in Generic Drug Applications Act
  2 filings
• HR 3269
  ETHIC Act
  1 filing
• HR 5526
  Biosimilar Red Tape Elimination Act
  1 filing
• S 1954
  Biosimilar Red Tape Elimination Act
  1 filing
• S 2276
  ETHIC Act
  1 filing
• S 2296
  National Defense Authorization Act for Fiscal Year 2026
  1 filing
• SJRES 37
  A joint resolution terminating the national emergency declared to impose duties on articles imported from Can…
  1 filing

• 2026 $1,460,000 2 filings
• 2025 $1,680,000 4 filings

• Manufacturing 6
• Health Issues 5
• Tariff (miscellaneous tariff bills) 4
• Copyright/Patent/Trademark 2
• Trade (domestic/foreign) 2

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

• HOUSE OF REPRESENTATIVES 6
• SENATE 6
• Natl Economic Council (NEC) 3
• U.S. Trade Representative (USTR) 3
• Natl Security Council (NSC) 2
• Office of Management & Budget (OMB) 2
• Bureau of Industry and Security (BIS) 1

• APOTEX INC. Canada named on 1 filing · highest disclosed ownership 0% · largest disclosed contribution $0

Section 7 of the LD-2: a foreign company or government that owns part of the client, pays toward the lobbying, or benefits from it. Figures are the highest single disclosure across these filings, not a sum: the same stake is re-disclosed each quarter.